U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895420) titled 'Comparing Intravitreal Injection Pain Scores Using Iheezo (Chloroprocaine Hcl Ophthalmic Gel 3%) Versus Subconjunctival Lidocaine (2%): A Randomized, Controlled Trial' on Oct. 19.

Brief Summary: This will be a prospective, randomized, controlled non-inferiority trial comparing the efficacy of Iheezo versus subconjunctival 2% lidocaine in reducing intravitreal injection pain scores up to 24 hours after injection.

Study Start Date: Oct. 30, 2025

Study Type: INTERVENTIONAL

Condition: No Condition

Intervention: DRUG: chloroprocaine HCL 3%

Topical anesthetic for intravitreal injection

DRUG: Subconjunctival Lidocaine

Procedural a...